China Gabapentin Drug Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the Gabapentin Drug industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • CSPC Ouyi Pharmaceutical

    • Teva

    • Alkem Laboratories

    • Marksans Pharma

    • Lupin Limited

    • Jiangsu Hengrui Medicine

    • Sun Pharmaceutical

    • Epic Pharma

    • Acella Pharmaceuticals

    • Mylan

    • Zydus Pharmaceuticals

    • Hi-Tech Pharmaceuticals

    • Tris Pharma

    • Depomed

    • Glenmark

    • Taro

    • InvaGen Pharmaceuticals

    • ACI HealthCare Limited

    • Sciegen Pharmaceuticals

    By Type:

    • Oral solution

    • Capsule

    • Tablet

    By Application:

    • Others

    • Partial onset seizures

    • Postherpetic neuralgia in adults

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Gabapentin Drug Market Overview 2018-2029

    • 1.1 China Gabapentin Drug Industry Development Overview

    • 1.2 China Gabapentin Drug Industry Development History

    • 1.3 China Gabapentin Drug Industry Market Size (2018-2029)

    • 1.4 China Gabapentin Drug Market Analysis by Type from Production Side

      • 1.4.1 China Gabapentin Drug Production Volume, Production Value and Growth Rate of Oral solution (2018-2029)

      • 1.4.2 China Gabapentin Drug Production Volume, Production Value and Growth Rate of Capsule (2018-2029)

      • 1.4.3 China Gabapentin Drug Production Volume, Production Value and Growth Rate of Tablet (2018-2029)

    • 1.5 China Gabapentin Drug Market Analysis by Application from Consumption End

      • 1.5.1 China Gabapentin Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Gabapentin Drug Sales Volume, Sales Value and Growth Rate of Partial onset seizures (2018-2029)

      • 1.5.3 China Gabapentin Drug Sales Volume, Sales Value and Growth Rate of Postherpetic neuralgia in adults (2018-2029)

    • 1.6 China Gabapentin Drug Market Analysis by Region

      • 1.6.1 North China Gabapentin Drug Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Gabapentin Drug Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Gabapentin Drug Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Gabapentin Drug Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Gabapentin Drug Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Gabapentin Drug Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Gabapentin Drug Market Size and Growth Rate from 2018-2029

    Chapter 2 China Gabapentin Drug Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Gabapentin Drug Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Gabapentin Drug Market Status and Competition Analysis in 2023

      • 2.2.3 China Gabapentin Drug Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Gabapentin Drug Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Gabapentin Drug Industry Development

    Chapter 3 Gabapentin DrugIndustry Chain Analysis

    • 3.1 Gabapentin Drug Industry Chain

    • 3.2 Gabapentin Drug Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Gabapentin Drug Market

    • 3.3 Gabapentin Drug Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Gabapentin Drug Market

    Chapter 4 China Gabapentin Drug Market, by Type

    • 4.1 China Gabapentin Drug Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Gabapentin Drug Total Production Volume and Growth Rate from Production Side

    • 4.5 China Gabapentin Drug Production Volume and Growth Rate, by Type

      • 4.5.1 China Gabapentin Drug Production Volume and Growth Rate of Oral solution

      • 4.5.2 China Gabapentin Drug Production Volume and Growth Rate of Capsule

      • 4.5.3 China Gabapentin Drug Production Volume and Growth Rate of Tablet

    Chapter 5 China Gabapentin Drug Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Gabapentin Drug Total Market Size and Growth Rate from Consumption End

    • 5.5 China Gabapentin Drug Market Size and Growth Rate, by Application

      • 5.5.1 China Gabapentin Drug Market Size and Growth Rate of Others

      • 5.5.2 China Gabapentin Drug Market Size and Growth Rate of Partial onset seizures

      • 5.5.3 China Gabapentin Drug Market Size and Growth Rate of Postherpetic neuralgia in adults

    Chapter 6 China Gabapentin Drug Market, by Region

    • 6.1 China Gabapentin Drug Production Volume and Production Value, by Region

    • 6.2 China Gabapentin Drug Sales Volume and Sales Value, by Region

    Chapter 7 North China Gabapentin Drug Market Analysis

    • 7.1 North China Gabapentin Drug Market, by Type

    • 7.2 North China Gabapentin Drug Market, by Application

    Chapter 8 Central China Gabapentin Drug Market Analysis

    • 8.1 Central China Gabapentin Drug Market, by Type

    • 8.2 Central China Gabapentin Drug Market, by Application

    Chapter 9 South China Gabapentin Drug Market Analysis

    • 9.1 South China Gabapentin Drug Market, by Type

    • 9.2 South China Gabapentin Drug Market, by Application

    Chapter 10 East China Gabapentin Drug Market Analysis

    • 10.1 East China Gabapentin Drug Market, by Type

    • 10.2 East China Gabapentin Drug Market, by Application

    Chapter 11 Northeast China Gabapentin Drug Market Analysis

    • 11.1 Northeast China Gabapentin Drug Market, by Type

    • 11.2 Northeast China Gabapentin Drug Market, by Application

    Chapter 12 Southwest China Gabapentin Drug Market Analysis

    • 12.1 Southwest China Gabapentin Drug Market, by Type

    • 12.2 Southwest China Gabapentin Drug Market, by Application

    Chapter 13 Northwest China Gabapentin Drug Market Analysis

    • 13.1 Northwest China Gabapentin Drug Market, by Type

    • 13.2 Northwest China Gabapentin Drug Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Gabapentin Drug Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 CSPC Ouyi Pharmaceutical

        • 14.2.1 CSPC Ouyi Pharmaceutical Company Profile

        • 14.2.2 CSPC Ouyi Pharmaceutical Gabapentin Drug Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Teva

        • 14.3.1 Teva Company Profile

        • 14.3.2 Teva Gabapentin Drug Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Alkem Laboratories

        • 14.4.1 Alkem Laboratories Company Profile

        • 14.4.2 Alkem Laboratories Gabapentin Drug Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Marksans Pharma

        • 14.5.1 Marksans Pharma Company Profile

        • 14.5.2 Marksans Pharma Gabapentin Drug Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Lupin Limited

        • 14.6.1 Lupin Limited Company Profile

        • 14.6.2 Lupin Limited Gabapentin Drug Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Jiangsu Hengrui Medicine

        • 14.7.1 Jiangsu Hengrui Medicine Company Profile

        • 14.7.2 Jiangsu Hengrui Medicine Gabapentin Drug Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Sun Pharmaceutical

        • 14.8.1 Sun Pharmaceutical Company Profile

        • 14.8.2 Sun Pharmaceutical Gabapentin Drug Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Epic Pharma

        • 14.9.1 Epic Pharma Company Profile

        • 14.9.2 Epic Pharma Gabapentin Drug Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Acella Pharmaceuticals

        • 14.10.1 Acella Pharmaceuticals Company Profile

        • 14.10.2 Acella Pharmaceuticals Gabapentin Drug Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Mylan

        • 14.11.1 Mylan Company Profile

        • 14.11.2 Mylan Gabapentin Drug Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Zydus Pharmaceuticals

        • 14.12.1 Zydus Pharmaceuticals Company Profile

        • 14.12.2 Zydus Pharmaceuticals Gabapentin Drug Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Hi-Tech Pharmaceuticals

        • 14.13.1 Hi-Tech Pharmaceuticals Company Profile

        • 14.13.2 Hi-Tech Pharmaceuticals Gabapentin Drug Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Tris Pharma

        • 14.14.1 Tris Pharma Company Profile

        • 14.14.2 Tris Pharma Gabapentin Drug Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Depomed

        • 14.15.1 Depomed Company Profile

        • 14.15.2 Depomed Gabapentin Drug Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Glenmark

        • 14.16.1 Glenmark Company Profile

        • 14.16.2 Glenmark Gabapentin Drug Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Taro

        • 14.17.1 Taro Company Profile

        • 14.17.2 Taro Gabapentin Drug Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 InvaGen Pharmaceuticals

        • 14.18.1 InvaGen Pharmaceuticals Company Profile

        • 14.18.2 InvaGen Pharmaceuticals Gabapentin Drug Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 ACI HealthCare Limited

        • 14.19.1 ACI HealthCare Limited Company Profile

        • 14.19.2 ACI HealthCare Limited Gabapentin Drug Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Sciegen Pharmaceuticals

        • 14.20.1 Sciegen Pharmaceuticals Company Profile

        • 14.20.2 Sciegen Pharmaceuticals Gabapentin Drug Market Performance

        • 14.20.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Gabapentin Drug Industry Research Conclusions

    • 15.2 Gabapentin Drug Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Gabapentin Drug Industry Market Size (2018-2029)

    • Figure China Gabapentin Drug Production Volume, Production Value and Growth Rate of Oral solution (2018-2029)

    • Figure China Gabapentin Drug Production Volume, Production Value and Growth Rate of Capsule (2018-2029)

    • Figure China Gabapentin Drug Production Volume, Production Value and Growth Rate of Tablet (2018-2029)

    • Figure China Gabapentin Drug Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Gabapentin Drug Sales Volume, Sales Value and Growth Rate of Partial onset seizures (2018-2029)

    • Figure China Gabapentin Drug Sales Volume, Sales Value and Growth Rate of Postherpetic neuralgia in adults (2018-2029)

    • Figure North China Gabapentin Drug Market Size and Growth Rate from 2018-2029

    • Figure Central China Gabapentin Drug Market Size and Growth Rate from 2018-2029

    • Figure South China Gabapentin Drug Market Size and Growth Rate from 2018-2029

    • Figure East China Gabapentin Drug Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Gabapentin Drug Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Gabapentin Drug Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Gabapentin Drug Market Size and Growth Rate from 2018-2029

    • Figure Gabapentin Drug Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Gabapentin Drug Market Share by Type in 2018

    • Figure China Gabapentin Drug Market Share by Type in 2023

    • Figure China Gabapentin Drug Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Gabapentin Drug Production Volume and Growth Rate of Oral solution (2018-2023)

    • Figure China Gabapentin Drug Production Volume and Growth Rate of Capsule (2018-2023)

    • Figure China Gabapentin Drug Production Volume and Growth Rate of Tablet (2018-2023)

    • Figure China Gabapentin Drug Market Share by Application in 2018

    • Figure China Gabapentin Drug Market Share by Application in 2023

    • Figure China Gabapentin Drug Total Market Size and Growth Rate from Consumption End

    • Figure China Gabapentin Drug Market Size and Growth Rate of Others (2018-2023)

    • Figure China Gabapentin Drug Market Size and Growth Rate of Partial onset seizures (2018-2023)

    • Figure China Gabapentin Drug Market Size and Growth Rate of Postherpetic neuralgia in adults (2018-2023)

    • Table China Gabapentin Drug Production Volume by Region (2018-2023)

    • Table China Gabapentin Drug Production Volume Share by Region (2018-2023)

    • Figure China Gabapentin Drug Production Volume Share by Region (2018-2023)

    • Table China Gabapentin Drug Production Value by Region (2018-2023)

    • Table China Gabapentin Drug Production Value Share by Region (2018-2023)

    • Figure China Gabapentin Drug Production Value Share by Region (2018-2023)

    • Table China Gabapentin Drug Sales Volume by Region (2018-2023)

    • Table China Gabapentin Drug Sales Volume Share by Region (2018-2023)

    • Figure China Gabapentin Drug Sales Volume Share by Region (2018-2023)

    • Table China Gabapentin Drug Sales Value by Region (2018-2023)

    • Table China Gabapentin Drug Sales Value Share by Region (2018-2023)

    • Figure China Gabapentin Drug Sales Value Share by Region (2018-2023)

    • Table North China Gabapentin Drug Production Volume by Type (2018-2023)

    • Table North China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Figure North China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Table North China Gabapentin Drug Sales Volume by Application (2018-2023)

    • Table North China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Figure North China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Table Central China Gabapentin Drug Production Volume by Type (2018-2023)

    • Table Central China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Figure Central China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Table Central China Gabapentin Drug Sales Volume by Application (2018-2023)

    • Table Central China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Figure Central China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Table South China Gabapentin Drug Production Volume by Type (2018-2023)

    • Table South China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Figure South China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Table South China Gabapentin Drug Sales Volume by Application (2018-2023)

    • Table South China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Figure South China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Table East China Gabapentin Drug Production Volume by Type (2018-2023)

    • Table East China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Figure East China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Table East China Gabapentin Drug Sales Volume by Application (2018-2023)

    • Table East China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Figure East China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Table Northeast China Gabapentin Drug Production Volume by Type (2018-2023)

    • Table Northeast China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Figure Northeast China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Table Northeast China Gabapentin Drug Sales Volume by Application (2018-2023)

    • Table Northeast China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Table Southwest China Gabapentin Drug Production Volume by Type (2018-2023)

    • Table Southwest China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Figure Southwest China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Table Southwest China Gabapentin Drug Sales Volume by Application (2018-2023)

    • Table Southwest China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Table Northwest China Gabapentin Drug Production Volume by Type (2018-2023)

    • Table Northwest China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Figure Northwest China Gabapentin Drug Production Volume Share by Type (2018-2023)

    • Table Northwest China Gabapentin Drug Sales Volume by Application (2018-2023)

    • Table Northwest China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Gabapentin Drug Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table CSPC Ouyi Pharmaceutical Company Profile

    • Table CSPC Ouyi Pharmaceutical Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Teva Company Profile

    • Table Teva Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Alkem Laboratories Company Profile

    • Table Alkem Laboratories Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Marksans Pharma Company Profile

    • Table Marksans Pharma Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Lupin Limited Company Profile

    • Table Lupin Limited Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Jiangsu Hengrui Medicine Company Profile

    • Table Jiangsu Hengrui Medicine Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Sun Pharmaceutical Company Profile

    • Table Sun Pharmaceutical Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Epic Pharma Company Profile

    • Table Epic Pharma Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Acella Pharmaceuticals Company Profile

    • Table Acella Pharmaceuticals Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Mylan Company Profile

    • Table Mylan Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Zydus Pharmaceuticals Company Profile

    • Table Zydus Pharmaceuticals Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Hi-Tech Pharmaceuticals Company Profile

    • Table Hi-Tech Pharmaceuticals Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Tris Pharma Company Profile

    • Table Tris Pharma Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Depomed Company Profile

    • Table Depomed Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Glenmark Company Profile

    • Table Glenmark Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Taro Company Profile

    • Table Taro Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table InvaGen Pharmaceuticals Company Profile

    • Table InvaGen Pharmaceuticals Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table ACI HealthCare Limited Company Profile

    • Table ACI HealthCare Limited Gabapentin Drug Revenue, Price and Gross (2018-2023)

    • Table Sciegen Pharmaceuticals Company Profile

    • Table Sciegen Pharmaceuticals Gabapentin Drug Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.